AVAILABLE ON DEMAND
Advancements in Precision OncologY
Description: In this webinar, which you can now access on demand, you will learn about the advantages and limitations of precision oncology technologies—from genetic sequencing to the rapidly developing field of functional precision medicine (FPM), which involves exposing live tumor cells from affected individuals to a variety of therapies, then evaluating tumor response to help bring greater certainty to personalized cancer treatment decisions.
Presented by: Jonathan Nakashima, PhD, Certis Chief Scientific Officer
The Precision Oncology Toolbox
- Standard of Care
- Genetic Profiling (Directional)
- In Vitro Screens (Functional)
- In Vivo Testing (Functional)
ACCESS NOW
Recognized for Innovation in Functional Precision Oncology
About Us
Certis Oncology Solutions is a life science technology company dedicated to precision oncology and translational science. Our mission is to connect every patient to the right cancer treatment, the first time, every time. Certis explores options for precision therapies beyond the current standard of care and partners with pharmaceutical companies to help develop the next generation of targeted therapeutics.
YOURPDX IS A FUNCTIONAL TEST THAT MEASURES THERAPEUTIC RESPONSE IN PERSONALIZED PATIENT-DERIVED XENOGRAFT MODELS. TEST RESULTS ARE NOT A REPLACEMENT FOR MEDICAL ADVICE. TREATMENT DECISIONS ARE THE RESPONSIBILITY OF PATIENTS AND THEIR PHYSICIANS. YOURPDX TESTING REQUIRES FRESH TUMOR TISSUE. IT IS ESSENTIAL TO CONTACT US PRIOR TO BIOPSY OR RESECTION SURGERY. TESTIMONIALS APPEARING ON THIS SITE REFLECT REAL-LIFE EXPERIENCES OF THOSE WHO HAVE USED OUR SERVICES.